Compare $CTKB vs $DNA | Chartloom

Compare

$CTKB vs $DNA

Cytek Biosciences Inc · Ginkgo Bioworks Holdings Inc

CTKB

Cytek Biosciences Inc

DNA

Ginkgo Bioworks Holdings Inc

Compare $CTKB vs $DNA

Comparing Cytek Biosciences Inc and Ginkgo Bioworks Holdings Inc

CTKBCytek Biosciences Inc

DNAGinkgo Bioworks Holdings Inc

CTKBCytek Biosciences Inc

Market cap

$701M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.18x

Rev growth (TTM)

5.4%

YTD performance

10.4%

52W performance

39.2%

FCF yield

-1.7%

DNAGinkgo Bioworks Holdings Inc

Market cap

$810M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-51.5%

YTD performance

49.4%

52W performance

-19.2%

FCF yield

-21.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CTKB

DNA

Detailed metrics comparison

CTKB

Cytek Biosciences Inc

DNA

Ginkgo Bioworks Holdings Inc

Market Cap

CTKB$701M

DNA$810M

Enterprise Value

CTKB$637M

DNA$726M

Price

CTKB$5.43

DNA$13.00

P/E Ratio

CTKBN/A

DNAN/A

P/S Ratio

CTKB3.39x

DNA7.24x

EV/Sales

CTKB3.08x

DNA6.49x

EV/EBITDA

CTKB1,027.69x

DNA0.00x

P/B Ratio

CTKB2.37x

DNA1.98x

P/FCF Ratio

CTKBN/A

DNAN/A

EV/FCF

CTKB-52.35x

DNA-4.15x

PEG Ratio

CTKBN/A

DNAN/A

Forward P/E (NTM)

CTKBN/A

DNAN/A

Forward P/S (NTM)

CTKB3.18x

DNAN/A

Revenue (TTM)

CTKB$207M

DNA$112M

Revenue Growth (YoY)

CTKB5.4%

DNA-51.5%

Forward Rev Growth

CTKB6.1%

DNA13.4%

Gross Margin (TTM)

CTKB53.2%

DNA77.7%

Operating Margin (TTM)

CTKB0.0%

DNA0.0%

EBITDA Margin (TTM)

CTKB-17.9%

DNA-210.7%

Net Margin (TTM)

CTKB-39.0%

DNA-260.0%

FCF Margin (TTM)

CTKB-5.9%

DNA-156.3%

Net Income (TTM)

CTKB$-81M

DNA$-291M

FCF (TTM)

CTKB$-12M

DNA$-175M

EPS (TTM)

CTKB-$0.62

DNA-$4.68

ROE (TTM)

CTKB-2353.0%

DNA-6021.0%

ROA (TTM)

CTKB-1740.0%

DNA-2685.0%

ROIC (TTM)

CTKB-2293.0%

DNA-6021.0%

Cash

CTKB$74M

DNA$85M

Debt

CTKB$10M

DNA$0

Net Cash/Debt

CTKB$64M

DNA$85M

Current Ratio (TTM)

CTKB4.48x

DNA4.57x

Quick Ratio (TTM)

CTKB3.77x

DNA4.37x

Debt/Equity (TTM)

CTKB0.03x

DNA0.00x

Debt/Assets (TTM)

CTKB0.0%

DNA0.0%

Interest Coverage (TTM)

CTKBN/A

DNAN/A

Net Debt/EBITDA (TTM)

CTKB0.00x

DNA0.00x

Beta

CTKB1.15

DNA1.69

52W Performance

CTKB39.2%

DNA-19.2%

YTD Performance

CTKB10.4%

DNA49.4%

% from 52W High

CTKB-12.6%

DNA-28.6%

% from 52W Low

CTKB64.0%

DNA142.1%

Asset Turnover (TTM)

CTKB0.45x

DNA0.10x

FCF Yield (TTM)

CTKB-1.7%

DNA-21.6%

Earnings Yield (TTM)

CTKB-11.5%

DNA-35.9%

Dividend Yield (TTM)

CTKBN/A

DNAN/A

Rule of 40

CTKB-0.4

DNA-207.8

EV/GP/RG

CTKB0.61

DNA0.42

Ticker research

View CTKB research View DNA research

Metric	CTKB Cytek Biosciences Inc	DNA Ginkgo Bioworks Holdings Inc
Market & Valuation
Market Cap	$701M	$810M
Enterprise Value	$637M	$726M
Price	$5.43	$13.00
P/E Ratio	N/A	N/A
P/S Ratio	3.39x	7.24x
EV/Sales	3.08x	6.49x
EV/EBITDA	1,027.69x	0.00x
P/B Ratio	2.37x	1.98x
P/FCF Ratio	N/A	N/A
EV/FCF	-52.35x	-4.15x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.18x	N/A
Revenue & Growth
Revenue (TTM)	$207M	$112M
Revenue Growth (YoY)	5.4%	-51.5%
Forward Rev Growth	6.1%	13.4%
Profitability
Gross Margin (TTM)	53.2%	77.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-17.9%	-210.7%
Net Margin (TTM)	-39.0%	-260.0%
FCF Margin (TTM)	-5.9%	-156.3%
Net Income (TTM)	$-81M	$-291M
FCF (TTM)	$-12M	$-175M
EPS (TTM)	-$0.62	-$4.68
ROE (TTM)	-2353.0%	-6021.0%
ROA (TTM)	-1740.0%	-2685.0%
ROIC (TTM)	-2293.0%	-6021.0%
Financial Health
Cash	$74M	$85M
Debt	$10M	$0
Net Cash/Debt	$64M	$85M
Current Ratio (TTM)	4.48x	4.57x
Quick Ratio (TTM)	3.77x	4.37x
Debt/Equity (TTM)	0.03x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.15	1.69
52W Performance	39.2%	-19.2%
YTD Performance	10.4%	49.4%
% from 52W High	-12.6%	-28.6%
% from 52W Low	64.0%	142.1%
Efficiency & Yields
Asset Turnover (TTM)	0.45x	0.10x
FCF Yield (TTM)	-1.7%	-21.6%
Earnings Yield (TTM)	-11.5%	-35.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-0.4	-207.8
EV/GP/RG	0.61	0.42
Ticker research	View CTKB research	View DNA research

Valuation

P/S Ratio

CTKB

3.39x

DNA

7.24x

EV/FCF

CTKB

-52.35x

DNA

-4.15x

Growth & revenue

Revenue Growth TTM

CTKB

5.4%

DNA

-51.5%

Forward Revenue Growth

DNA

13.4%

CTKB

6.1%

Profitability & performance

Gross Margin

DNA

77.7%

CTKB

53.2%

ROE

CTKB

-2353.0%

DNA

-6021.0%

FCF Yield %

CTKB

-1.7%

DNA

-21.6%

52-Week Performance

CTKB

39.2%

DNA

-19.2%

Detailed metrics comparison

CTKB

Cytek Biosciences Inc

DNA

Ginkgo Bioworks Holdings Inc

Market Cap

CTKB$701M

DNA$810M

Enterprise Value

CTKB$637M

DNA$726M

Price

CTKB$5.43

DNA$13.00

P/E Ratio

CTKBN/A

DNAN/A

P/S Ratio

CTKB3.39x

DNA7.24x

EV/Sales

CTKB3.08x

DNA6.49x

EV/EBITDA

CTKB1,027.69x

DNA0.00x

P/B Ratio

CTKB2.37x

DNA1.98x

P/FCF Ratio

CTKBN/A

DNAN/A

EV/FCF

CTKB-52.35x

DNA-4.15x

PEG Ratio

CTKBN/A

DNAN/A

Forward P/E (NTM)

CTKBN/A

DNAN/A

Forward P/S (NTM)

CTKB3.18x

DNAN/A

Revenue (TTM)

CTKB$207M

DNA$112M

Revenue Growth (YoY)

CTKB5.4%

DNA-51.5%

Forward Rev Growth

CTKB6.1%

DNA13.4%

Gross Margin (TTM)

CTKB53.2%

DNA77.7%

Operating Margin (TTM)

CTKB0.0%

DNA0.0%

EBITDA Margin (TTM)

CTKB-17.9%

DNA-210.7%

Net Margin (TTM)

CTKB-39.0%

DNA-260.0%

FCF Margin (TTM)

CTKB-5.9%

DNA-156.3%

Net Income (TTM)

CTKB$-81M

DNA$-291M

FCF (TTM)

CTKB$-12M

DNA$-175M

EPS (TTM)

CTKB-$0.62

DNA-$4.68

ROE (TTM)

CTKB-2353.0%

DNA-6021.0%

ROA (TTM)

CTKB-1740.0%

DNA-2685.0%

ROIC (TTM)

CTKB-2293.0%

DNA-6021.0%

Cash

CTKB$74M

DNA$85M

Debt

CTKB$10M

DNA$0

Net Cash/Debt

CTKB$64M

DNA$85M

Current Ratio (TTM)

CTKB4.48x

DNA4.57x

Quick Ratio (TTM)

CTKB3.77x

DNA4.37x

Debt/Equity (TTM)

CTKB0.03x

DNA0.00x

Debt/Assets (TTM)

CTKB0.0%

DNA0.0%

Interest Coverage (TTM)

CTKBN/A

DNAN/A

Net Debt/EBITDA (TTM)

CTKB0.00x

DNA0.00x

Beta

CTKB1.15

DNA1.69

52W Performance

CTKB39.2%

DNA-19.2%

YTD Performance

CTKB10.4%

DNA49.4%

% from 52W High

CTKB-12.6%

DNA-28.6%

% from 52W Low

CTKB64.0%

DNA142.1%

Asset Turnover (TTM)

CTKB0.45x

DNA0.10x

FCF Yield (TTM)

CTKB-1.7%

DNA-21.6%

Earnings Yield (TTM)

CTKB-11.5%

DNA-35.9%

Dividend Yield (TTM)

CTKBN/A

DNAN/A

Rule of 40

CTKB-0.4

DNA-207.8

EV/GP/RG

CTKB0.61

DNA0.42

Ticker research

View CTKB research View DNA research

Metric	CTKB Cytek Biosciences Inc	DNA Ginkgo Bioworks Holdings Inc
Market & Valuation
Market Cap	$701M	$810M
Enterprise Value	$637M	$726M
Price	$5.43	$13.00
P/E Ratio	N/A	N/A
P/S Ratio	3.39x	7.24x
EV/Sales	3.08x	6.49x
EV/EBITDA	1,027.69x	0.00x
P/B Ratio	2.37x	1.98x
P/FCF Ratio	N/A	N/A
EV/FCF	-52.35x	-4.15x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.18x	N/A
Revenue & Growth
Revenue (TTM)	$207M	$112M
Revenue Growth (YoY)	5.4%	-51.5%
Forward Rev Growth	6.1%	13.4%
Profitability
Gross Margin (TTM)	53.2%	77.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-17.9%	-210.7%
Net Margin (TTM)	-39.0%	-260.0%
FCF Margin (TTM)	-5.9%	-156.3%
Net Income (TTM)	$-81M	$-291M
FCF (TTM)	$-12M	$-175M
EPS (TTM)	-$0.62	-$4.68
ROE (TTM)	-2353.0%	-6021.0%
ROA (TTM)	-1740.0%	-2685.0%
ROIC (TTM)	-2293.0%	-6021.0%
Financial Health
Cash	$74M	$85M
Debt	$10M	$0
Net Cash/Debt	$64M	$85M
Current Ratio (TTM)	4.48x	4.57x
Quick Ratio (TTM)	3.77x	4.37x
Debt/Equity (TTM)	0.03x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.15	1.69
52W Performance	39.2%	-19.2%
YTD Performance	10.4%	49.4%
% from 52W High	-12.6%	-28.6%
% from 52W Low	64.0%	142.1%
Efficiency & Yields
Asset Turnover (TTM)	0.45x	0.10x
FCF Yield (TTM)	-1.7%	-21.6%
Earnings Yield (TTM)	-11.5%	-35.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-0.4	-207.8
EV/GP/RG	0.61	0.42
Ticker research	View CTKB research	View DNA research